Patents by Inventor Jonathan Heeney

Jonathan Heeney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AGENT
    Publication number: 20160002320
    Abstract: Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions.
    Type: Application
    Filed: July 7, 2015
    Publication date: January 7, 2016
    Applicant: AIMSCO LIMITED
    Inventors: Angus G. Dalgleish, Martin Cadogan, Jonathan Heeney, Stanley D.T. White
  • Recombinant vectors based on the modified vaccinia ankara virus (MVA) as preventive and therapeutic vaccines against AIDS
    Patent number: 8871219
    Abstract: Recombinant vectors which are based on the Modified Ankara Virus (MVA) as preventive and therapeutic vaccines against AIDS. The recombinant viruses contain sequences which are inserted at an MVA insertion site and enable simultaneous expression of antigens, a HIV-1 Env protein consisting of a gp120 protein lacking sequences corresponding to protein gp 41 and a chimeric fusion protein of Gag, Pol and Nef. These viruses are stable and can trigger immune responses against a large variety of antigens. Viruses having a chimeric protein from HIV-1 are suitable for the preparation of vaccines against AIDS.
    Type: Grant
    Filed: July 25, 2006
    Date of Patent: October 28, 2014
    Assignee: Consejo Superior de Investigaciones Cientificas
    Inventors: Jonathan Heeney, Petra Mooij, Carmen Elena Gomez Rodriguez, Jose Luis Najera Garcia, Victoria Jimenez Tentor, Mariano Esteban Rodriguez
  • THERAPEUTIC AGENT
    Publication number: 20130230600
    Abstract: Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions.
    Type: Application
    Filed: February 8, 2013
    Publication date: September 5, 2013
    Applicant: AIMSCO LIMITED
    Inventors: Angus G. Dalgleish, Martin Cadogan, Jonathan Heeney, Stanley D.T. White
  • Therapeutic Agent
    Publication number: 20120100156
    Abstract: Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions.
    Type: Application
    Filed: December 9, 2011
    Publication date: April 26, 2012
    Inventors: Angus G. Dalgleish, Martin Cadogan, Jonathan Heeney, Stanley D. T. White
  • Treatment of MS with goat serum
    Publication number: 20110086046
    Abstract: A serum composition from a goat immunised with HIV contains anti-HLA antibody and is suited for palliative improvement of the condition of an animal.
    Type: Application
    Filed: January 28, 2003
    Publication date: April 14, 2011
    Inventors: Jonathan Heeney, Angus G. Dalgleish, Stanley D.T. White
  • Therapeutic Agent
    Publication number: 20100291102
    Abstract: Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions.
    Type: Application
    Filed: July 2, 2002
    Publication date: November 18, 2010
    Applicant: ICE BIOLOGICS LIMITED
    Inventors: Angus G. Dalgleish, Martin Cadogan, Jonathan Heeney, Stanley D.T. White
  • Recombinant Vectors Based On the Modified Vaccinia Ankara Virus (MVA) as Preventive and Therapeutic Vaccines Against Aids
    Publication number: 20100047276
    Abstract: Recombinant vectors which are based on the Modified Ankara Virus (MVA) as preventive and therapeutic vaccines against AIDS. The recombinant viruses object of the invention contain sequences which are inserted at the same MVA insertion site and which enable the simultaneous expression of various antigens, a HIV-1 Env protein consisting of a gp120 protein lacking sequences corresponding to protein gp 41 and a chimeric fusion protein of Gag, Pol and Nef. Said viruses are stable and can trigger immune responses against a large variety of antigens.
    Type: Application
    Filed: July 25, 2006
    Publication date: February 25, 2010
    Inventors: Jonathan Heeney, Petra Mooij, Carmen Elena Gomez Rodriguez, Jose Luis Najera Garcia, Victoria Jimenez Tentor, Mariano Esteban Rodriguez
  • Product and method for obtaining specific immunisation with one or more antigens
    Publication number: 20050002967
    Abstract: The invention provides means and methods for vaccinating an animal or a human to obtain therein an immune response against at least one antigen, comprising different vaccine compositions for sequential administration to said animal or said human, each containing at least said antigen or a precursor thereof, wherein said vaccine compositions differ from each other by the presence therein of a different vector.
    Type: Application
    Filed: May 3, 2004
    Publication date: January 6, 2005
    Inventor: Jonathan Heeney